Lv21
150 积分 2025-12-16 加入
Comparison of efficacy and safety of pioglitazone and SGLT2 inhibitors in treating Asian patients in MASLD associated with type 2 diabetes: A meta-analysis
7小时前
已完结
BMI versus obesity subtypes in the era of precision medicine
22天前
已完结
Assessment of obesity beyond body mass index to determine benefit of treatment
22天前
已完结
Weight stigma experienced by patients with obesity in healthcare settings: A qualitative evidence synthesis
22天前
已完结
Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation
22天前
已完结
Metabolically healthy obesity
1个月前
已完结
Pathophysiology of Human Visceral Obesity: An Update
1个月前
已完结
Metabolically healthy versus metabolically unhealthy obesity
1个月前
已完结
Newly defined clinical obesity versus body mass index ‐defined obesity: Differential risks of overall death and adverse events in a population‐based cohort
1个月前
已完结
Newly defined clinical obesity versus body mass index ‐defined obesity: Differential risks of overall death and adverse events in a population‐based cohort
1个月前
已完结
皖公网安备34019202002308
